Read by QxMD icon Read

pregnancy and the hyperprolactinemic woman

Marcin Kałuzny, Marek Bolanowski
Hyperprolactinemia is one of the most common endocrinological disorders. The main clinical symptoms are limited to hypogonadism, which manifests as fertility disturbances, oligo- or amenorrhea in women, and libido loss, impotence, and fertility disturbances in men, as well as bone density disturbances (osteopenia, osteoporosis) and alactorrhea. Hyperprolactinemia is caused in most cases by drugs or it has an organic etiology (pituitary tumor:--prolactinoma). Differentiation between these two causes is very important for both therapeutic decisions and prognosis...
2005: Postȩpy Higieny i Medycyny Doświadczalnej
G Ricci, E Giolo, G Nucera, C Pozzobon, F De Seta, S Guaschino
Vaginal bromocriptine has proven safe and effective in treating hyperprolactinemic women. However, there has been no long-term clinical assessment regarding the influence of daily vaginal bromocriptine administration on the ability to conceive. This article presents two cases of successful pregnancy resulting from this alternative treatment. An infertile woman with an empty sella and hyperprolactinemia was treated with vaginal bromocriptine because of intolerance to oral administration. Prolactin levels were quickly normalized and no side effects occurred...
2001: Gynecologic and Obstetric Investigation
E Robert, L Musatti, G Piscitelli, C I Ferrari
The goal of this article is to assess the reproductive safety of cabergoline, a new ergot derivative proposed in hyperprolactinemic disorders. Investigated in different animal species, the drug showed no teratogenic or embryotoxic effects on rabbits. Considering the dose envisaged for humans, large safety margins exist. Our sample consists of 226 pregnancies occuring in 205 women. Follow-up is available for 204. There were 24 miscarriages and three abortions induced because of major malformations (one Down syndrome in a 42-year-old woman, one limb-body wall complex, one hydrocephalus)...
July 1996: Reproductive Toxicology
P G Whittaker, T Wilcox, T Lind
The heterogeneity of serum PRL in a hyperprolactinemic but fertile woman (Patient A) was studied by gel chromatography. Ninety percent of her PRL eluted with the void volume as "big, big" PRL and only 6% coincided with monomeric "little" PRL. Sera from a woman who had hyperprolactinemia associated with infertility (Patient B) and a normal woman (Patient C) exhibited the usual heterogeneous distribution, where 5% and 19%, respectively, eluted as big, big PRL and 76% and 65%, respectively, eluted as little PRL...
October 1981: Journal of Clinical Endocrinology and Metabolism
G A Fava, M Fava, R Kellner, E Serafini, I Mastrogiacomo
In order to evaluate the relationship of psychological distress to hyperprolactinemia, 20 patients with secondary amenorrhea were evaluated by a semi-structured research interview and administered the Kellner Symptom Questionnaire. Group A (10 patients with amenorrhea and hyperprolactinemia) reported significantly more symptoms of depression, hostility and anxiety than group B (10 patients with amenorrhea and normal basal levels of plasma prolactin). Both groups were significantly more anxious, depressed and reported more somatic symptoms than a normal control group (n = 10)...
1981: Psychotherapy and Psychosomatics
I Cohen, J Blankstein, G Oelsner, B Lunenfeld, M Berezin
A hyperprolactinemic woman, who had been operated upon twice, in two consecutive pregnancies, because of progressive deterioration of a pituitary tumor, is presented. This case demonstrated the unpredictable behavior of pituitary tumors in pregnancy.
September 1984: European Journal of Obstetrics, Gynecology, and Reproductive Biology
R D Jackson, J Wortsman, W B Malarkey
This study reports the presence of a large molecular sized PRL as the major form of circulating immunoactive PRL in five women with idiopathic hyperprolactinemia and normal menses. Gel filtration patterns of serum from these patients revealed 98-100% predominance of a 150,000- to 160,000-dalton PRL in contrast to the predominance of the 22,000-dalton species in other hyperprolactinemic patients. This 150,000- to 160,000-dalton PRL was immunologically similar to the 22,000-dalton PRL, and its size on gel filtration was not altered using denaturing conditions...
August 1985: Journal of Clinical Endocrinology and Metabolism
M E Molitch
No abstract text is available yet for this article.
May 23, 1985: New England Journal of Medicine
F Larrea, A Escorza, A Valero, L Hernandez, M C Cravioto, V Diaz-Sanchez
We have demonstrated the selective secretion of high mol wt PRL series (big big PRL) in women with hyperprolactinemia and normal ovarian function. This observation suggests that big big PRL is immunologically similar, but biologically less active, than monomeric or little PRL. In this study we determined the molecular size heterogeneity of immunoreactive PRL in the serum from two ovulatory hyperprolactinemic women (subjects A and B) who had large amounts of serum big big PRL during a menstrual cycle and/or gestation...
May 1989: Journal of Clinical Endocrinology and Metabolism
E Pasinetti, M R Schivardi, L Falsetti, A Gastaldi
A woman who presented with amenorrhea and galactorrhea with a large prolactinoma (8.5 mm) which regressed on bromocriptine therapy is described. When treatment with bromocriptine was instituted (10 mg/daily) mean serum prolactin concentration fell from 490 ng/ml to 108 ng/ml. Despite a progressive reduction in size up to disappearance of the adenoma after the first 5 years of therapy, prolactin levels remained high. Bromocriptine treatment was stopped after 6 years, when pregnancy was diagnosed. Pregnancy proceeded without complications and lactation was initiated and maintained...
March 1989: Minerva Ginecologica
S Otani, S Usuki, H Iwasaki, S Inoue, K Yamashita
A hyperprolactinemic infertile woman with a pituitary microadenoma, who was resistant to bromocriptine as a method of bringing on pregnancy, succeeded in having a normal pregnancy and delivery with Hachimi-jio-gan treatment. This paper reports that the patient did not succeed in pregnancy in spite of 16 months of bromocriptine treatment, though her prolactin level gradually decreased and continued to be between 40-60 ng/ml with Hachimi-jio-gan treatment. Although the level of prolactin of the patient did not normalize, she, nevertheless, succeeded in having a normal pregnancy and delivery...
1991: American Journal of Chinese Medicine
M R Clemens, R Göser, E Keller, W Zubke, H Traut, A E Schindler
18 pregnancies occurred after treatment with bromoergocryptine in 17 patients who wished to conceive, but who suffered from anovulation of varying aetiology. The course of 15 pregnancies was uneventful. Three pregnancies ended in abortion. Nine of the 17 women had hyperprolactinemic amenorrhea. Furthermore, one woman had normoprolactinemic post-pill amenorrhea, another normoprolactinemic anovulatory oligomenorrhea and a third normoprolactinemic anovulatory regular menstruations. With the exception of one woman, all had galactorrhea...
May 12, 1978: Archiv Für Gynäkologie
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"